Hosts: Vincent Racaniello, Alan Dove, Dickson Despommier, and Brad Thompson
Hosts: Vincent, Alan, and Dickson chat with Brad Thompson, CEO of Oncolytics Biotech, about using reovirus to treat cancer.
[powerpress url=”http://traffic.libsyn.com/twiv/TWiV131.mp3″]
Click the arrow above to play, or right-click to download TWiV #131 (42 MB .mp3, 97 minutes).
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, by email, or listen on your mobile device with the Microbeworld app.
Links for this episode:
- Patrick Lee’s path to reolysin
- Reoviruses commonly infect humans
- Reovirus at ViralZone
- Onyx-411, an anti-tumor adenovirus
- BioVex, developers of OncoVEX GM-CSF
- This Week in Pediatric Oncology – TWiPO (iTunes)
- TWiV on Facebook
- Letters read on TWiV 131
Weekly Science Picks
Dickson – Angels and Insects
Alan – Science Buddies
Vincent – Emerging Diseases: The Importance of Early Warning and Surveillance (YouTube)
Listener Pick of the Week
Josh – Prof. Racaniello’s Virology course on iTunes
Send your virology questions and comments (email or mp3 file) to twiv@microbe.tv, or call them in to 908-312-0760. You can also post articles that you would like us to discuss at microbeworld.org and tag them with twiv.